IDIX had a webcast today to talk about its struggling HCV program; here’s the accompanying PR: http://finance.yahoo.com/news/idenix-announces-promising-clinical-data-110000190.html If anyone here listened to the CC (or plans to listen), please post your CC notes. T.i.a.